Energy_NN
substrates_NNS
,_,
hormone_NN
responses_NNS
and_CC
glucocorticoid_NN
binding_NN
in_IN
lymphocytes_NNS
during_IN
intense_JJ
physical_JJ
exercise_NN
in_IN
humans_NNS
following_VBG
phosphocreatine_JJ
administration_NN
._.

Eight_CD
healthy_JJ
untrained_JJ
male_JJ
volunteers_NNS
pedalled_VBD
a_DT
cycle_NN
ergometer_NN
according_VBG
to_TO
two_CD
exercise_NN
protocols_NNS
:_:
the_DT
first_JJ
involved_VBD
step-wise_RB
increasing_VBG
physical_JJ
exercise_NN
to_TO
maximal_JJ
-LRB-_-LRB-
MPE_NN
-RRB-_-RRB-
;_:
the_DT
second_JJ
involved_VBD
prolonged_JJ
-LRB-_-LRB-
35_CD
min_NN
-RRB-_-RRB-
submaximal_JJ
physical_JJ
exercise_NN
-LRB-_-LRB-
PPE_NN
-RRB-_-RRB-
at_IN
70_CD
%_NN
of_IN
the_DT
individual_NN
's_POS
maximal_JJ
oxygen_NN
uptake_NN
._.

Each_DT
volunteer_NN
performed_VBD
these_DT
exercise_NN
twice_RB
,_,
following_VBG
either_CC
an_DT
intravenous_JJ
injection_NN
of_IN
phosphocreatine_JJ
-LRB-_-LRB-
PCr_NN
-RRB-_-RRB-
or_CC
a_DT
placebo_NN
of_IN
an_DT
isotonic_JJ
NaCl_NN
solution_NN
._.

Anaerobic_JJ
threshold_NN
-LRB-_-LRB-
AT_NN
-RRB-_-RRB-
was_VBD
determined_VBN
from_IN
the_DT
point_NN
of_IN
departure_NN
of_IN
the_DT
ventilatory_JJ
response_NN
from_IN
linearity_NN
and_CC
from_IN
the_DT
sudden_JJ
increase_NN
in_IN
venous_JJ
blood_NN
lactate_NN
concentrations_NNS
during_IN
MPE_NN
._.

After_IN
exercise_NN
following_VBG
placebo_NN
administration_NN
we_PRP
observed_VBD
increases_NNS
in_IN
concentrations_NNS
of_IN
blood_NN
substrates_NNS
,_,
plasma_NN
adrenocorticotropin_NN
-LRB-_-LRB-
ACTH_NN
-RRB-_-RRB-
,_,
growth_NN
hormone_NN
and_CC
cortisol_NN
and_CC
in_IN
the_DT
number_NN
of_IN
glucocorticoid_NN
receptors_NNS
in_IN
lymphocytes_NNS
without_IN
changes_NNS
in_IN
the_DT
dissociation_NN
constant_NN
._.

Intravenous_JJ
administration_NN
of_IN
PCr_NN
-LRB-_-LRB-
starting_VBG
1_CD
day_NN
before_IN
exercise_NN
-RRB-_-RRB-
led_VBD
to_TO
an_DT
increase_NN
in_IN
the_DT
total_JJ
workload_NN
-LRB-_-LRB-
on_IN
average_NN
by_IN
5.8_CD
%_NN
-RRB-_-RRB-
and_CC
in_IN
AT_NN
-LRB-_-LRB-
on_IN
average_NN
by_IN
6.8_CD
%_NN
-RRB-_-RRB-
during_IN
MPE_NN
and_CC
to_TO
a_DT
better_JJR
tolerance_NN
of_IN
exercise_NN
during_IN
PPE_NN
._.

Following_VBG
PCr_NN
administration_NN
we_PRP
observed_VBD
lower_JJR
blood_NN
lactate_NN
concentrations_NNS
and_CC
different_JJ
patterns_NNS
of_IN
some_DT
enzyme_NN
activities_NNS
,_,
less_RBR
pronounced_JJ
changes_NNS
in_IN
plasma_NN
ACTH_NN
and_CC
cortisol_NN
concentrations_NNS
and_CC
in_IN
glucocorticoid_NN
binding_NN
in_IN
lymphocytes_NNS
,_,
but_CC
no_DT
changes_NNS
in_IN
plasma_NN
growth_NN
hormone_NN
concentrations_NNS
compared_VBD
to_TO
the_DT
placebo_NN
._.

The_DT
results_NNS
showed_VBD
that_IN
intense_JJ
physical_JJ
exercise_NN
led_VBD
not_RB
only_RB
to_TO
increases_NNS
in_IN
blood_NN
hormone_NN
concentrations_NNS
but_CC
also_RB
to_TO
an_DT
increase_NN
in_IN
the_DT
density_NN
of_IN
glucocorticoid_NN
receptors_NNS
in_IN
lymphocytes_NNS
._.

Intravenous_JJ
PCr_NN
injection_NN
led_VBD
to_TO
smaller_JJR
changes_NNS
in_IN
ACTH_NN
and_CC
cortisol_NN
concentrations_NNS
as_RB
well_RB
as_IN
to_TO
a_DT
lower_JJR
activation_NN
of_IN
glucocorticoid_NN
binding_NN
in_IN
lymphocytes_NNS
._.

